Does OFATUMUMAB Cause Post procedural infection? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Post procedural infection have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.0% of all adverse event reports for OFATUMUMAB.
9
Reports of Post procedural infection with OFATUMUMAB
0.0%
of all OFATUMUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Post procedural infection From OFATUMUMAB?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Post procedural infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Post procedural infection?
ADALIMUMAB (1,109)
ETANERCEPT (362)
METHOTREXATE (226)
INFLIXIMAB (223)
UPADACITINIB (188)
TOFACITINIB (184)
GOLIMUMAB (177)
VEDOLIZUMAB (166)
RISANKIZUMAB-RZAA (157)
USTEKINUMAB (150)
Which OFATUMUMAB Alternatives Have Lower Post procedural infection Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB